Gilead Sciences (GILD) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $125.05 +0.14%
Revenue Growth %: +4.4%
Financial Fact:
Net income attributable to Gilead: 3.33B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +4.4%
Financial Fact:
Net income attributable to Gilead: 3.33B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $3.15, $0.44 better than the analyst estimate of $2.71. Revenue for the quarter came in at $8.24 billion versus the consensus estimate of $7.61 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
- Green Dot and CommerceOne shareholders approve acquisition deal
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
